Finance entity
markets is the sole category represented across all 2 tracked stories. Auvelity is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 108-day span. The 5 average consequence score is below the beat benchmark of 6.5 in the same window.
Last mentioned: Aug 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 2 tracked stories. Auvelity is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 108-day span. The 5 average consequence score is below the beat benchmark of 6.5 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 3 for the same window. This profile follows 2 Finance stories mentioning Revolution Medicines across the period from March 22, 2026 to July 7, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 894 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Revolution Medicines. Shared-story counts are live from our verified record — not editorial picks.
A trio of biotech stocks generated staggering H1 2026 returns, with Revolution Medicines leading at +230%. Axsome Therapeutics' revenue more than doubled to $617.1 million, underscoring a market rotation into catalyst-driven, high-growth healthcare plays amid macro uncertainty.
DAFNA Capital Management reduced its position in Axogen by approximately 265,456 shares during the fourth quarter of 2025, a move valued at $6.53 million. Despite the trim, the hedge fund maintains a significant $15.6 million stake in the nerve-repair specialist, which has seen its stock price climb 71% over the past year.
Revolution Medicines is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
